Bioceltix S.A. (WSE:BCX)
Poland
· Delayed Price · Currency is PLN 106.40
+4.80 (4.72%)
Jun 4, 2025, 3:45 PM CET
Bioceltix Market Cap
Bioceltix has a market cap or net worth of 500.33 million as of June 4, 2025. Its market cap has increased by 80.84% in one year.
Market Cap
500.33M
Enterprise Value
467.75M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
106.40
Market Cap Chart
Since November 8, 2021, Bioceltix's market cap has increased from 115.04M to 500.33M, an increase of 334.92%. That is a compound annual growth rate of 50.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2025 | 500.33M | 15.98% |
| Dec 30, 2024 | 431.38M | 16.07% |
| Dec 29, 2023 | 371.65M | 179.48% |
| Dec 30, 2022 | 132.98M | -22.49% |
| Dec 30, 2021 | 171.57M | 49.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NEUCA | 3.16B |
| Synektik Spólka Akcyjna | 1.85B |
| Voxel | 1.62B |
| Celon Pharma | 1.18B |
| Ryvu Therapeutics | 708.63M |
| Selvita | 578.20M |
| Centrum Medyczne ENEL-MED | 557.12M |
| EMC Instytut Medyczny | 469.52M |